Skip to main content
Top
Published in: AIDS and Behavior 4/2017

01-04-2017 | Original Paper

Against the Odds: Syringe Exchange Policy Implementation in Indiana

Authors: Beth E. Meyerson, Carrie A. Lawrence, Laura Miller, Anthony Gillespie, Daniel Raymond, Kristen Kelley, D. J. Shannon

Published in: AIDS and Behavior | Issue 4/2017

Login to get access

Abstract

Indiana recently passed legislation allowing local governments to establish syringe exchanges. While the effectiveness of syringe exchange programming is established, there is a dearth of studies about associated policy adoption and implementation. This study documents the experiences of 24 Indiana counties engaged in the process of establishing syringe exchange programming under new state law. A mixed method, qualitative, exploratory case study was conducted from May 2015 to April 2016. We observed rapid and widespread policy adoption interest, and yet counties reported significant policy ambiguity, epidemiologic and resource capacity issues. The emergence of health commons involving information and tangible resource sharing networks allowed institutional rearrangement in the midst of resource scarcity; however, such rearrangement appeared to be a central threat to policy adoption and implementation given state structural barriers. The emerging commons could be a critical policy success factor, as it would achieve efficiencies not possible in the current resource environment, and can help achieve institutional rearrangement for the improvement of population health. Several recommendations for improvement are offered.
Literature
1.
go back to reference Indiana Code 16-41-7.5 Senate Enrolled ACT 461. Indiana Code 16-41-7.5 Senate Enrolled ACT 461.
2.
go back to reference Conrad C, Bradley HM, Broz D, Budda S, Chapman E, Galang RR, Hillman D, Hon J, Hoover KW, Patel MR, Perez A, Peters PJ, Pontones P, Roseberry JC, Sandoval M, Shields J, Walthal J, Waterhouse D, Weidle PJ, Wu H, Duwve JM. Community outbreak of HIV infection linked to injection drug use of Oxymorphone—Indiana 2015. MMWR. 2015;64(16):443–4.PubMed Conrad C, Bradley HM, Broz D, Budda S, Chapman E, Galang RR, Hillman D, Hon J, Hoover KW, Patel MR, Perez A, Peters PJ, Pontones P, Roseberry JC, Sandoval M, Shields J, Walthal J, Waterhouse D, Weidle PJ, Wu H, Duwve JM. Community outbreak of HIV infection linked to injection drug use of Oxymorphone—Indiana 2015. MMWR. 2015;64(16):443–4.PubMed
3.
go back to reference Bluthenthal RN, Anderson R, Flynn NM, Kral AH. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug Alcohol Depend. 2007;89(2–3):214–22.CrossRefPubMedPubMedCentral Bluthenthal RN, Anderson R, Flynn NM, Kral AH. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug Alcohol Depend. 2007;89(2–3):214–22.CrossRefPubMedPubMedCentral
4.
go back to reference Des Jarlais DC, Perlis T, Arasteh K, et al. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001. AIDS. 2005;19(Suppl 3):S20–5.CrossRefPubMed Des Jarlais DC, Perlis T, Arasteh K, et al. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001. AIDS. 2005;19(Suppl 3):S20–5.CrossRefPubMed
5.
go back to reference Hagan H, McGough JP, Thiede H, Weiss N, Hopkins S, Russell A. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol. 1999;149:203–13.CrossRefPubMed Hagan H, McGough JP, Thiede H, Weiss N, Hopkins S, Russell A. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol. 1999;149:203–13.CrossRefPubMed
6.
go back to reference Fisher DG, Fenaughty AM, Cagle HH, Wells RS. Needle exchange and injection drug use frequency: a randomized clinical trial. J AIDS. 2003;33(2):199–205. Fisher DG, Fenaughty AM, Cagle HH, Wells RS. Needle exchange and injection drug use frequency: a randomized clinical trial. J AIDS. 2003;33(2):199–205.
7.
go back to reference Henderson LA, Vlahov D, Celentano DD, Strathdee SA. Readiness for cessation of drug use among recent attenders and nonattenders of a needle exchange program. J Acquir Immune Defic Syndr. 2003;32(2):229–37.CrossRefPubMed Henderson LA, Vlahov D, Celentano DD, Strathdee SA. Readiness for cessation of drug use among recent attenders and nonattenders of a needle exchange program. J Acquir Immune Defic Syndr. 2003;32(2):229–37.CrossRefPubMed
8.
go back to reference Brooner R, Kidorf M, King V, et al. Drug abuse treatment success among needle exchange participants. Public Health Rep. 1998;113(Suppl 1):130–9. Brooner R, Kidorf M, King V, et al. Drug abuse treatment success among needle exchange participants. Public Health Rep. 1998;113(Suppl 1):130–9.
9.
go back to reference Institute of Medicine Committee on HIV Prevention Strategies in the United States. No time to lose: getting more from HIV prevention. Washington, DC: National Academy Press; 2002. Institute of Medicine Committee on HIV Prevention Strategies in the United States. No time to lose: getting more from HIV prevention. Washington, DC: National Academy Press; 2002.
10.
go back to reference Lurie P, Gorsky R, Jones TS, Shompe L. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users. J AIDS. 1998;18(Supp1):S126–32. Lurie P, Gorsky R, Jones TS, Shompe L. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users. J AIDS. 1998;18(Supp1):S126–32.
11.
go back to reference Coffin PO, Latka MH, et al. Safe syringe disposal is related to safe syringe access among HIV-positive injection drug users. AIDS Behav. 2007;11:653–62.CrossRef Coffin PO, Latka MH, et al. Safe syringe disposal is related to safe syringe access among HIV-positive injection drug users. AIDS Behav. 2007;11:653–62.CrossRef
12.
go back to reference Bluthenthal RN, Ridgeway G, Schell T, et al. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users. Addiction. 2007;102:638–46.CrossRefPubMed Bluthenthal RN, Ridgeway G, Schell T, et al. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users. Addiction. 2007;102:638–46.CrossRefPubMed
13.
go back to reference Doherty MC, Garfein RS, Vlahov D, et al. Discarded needles do not increase soon after the opening of a needle exchange program. Am J Epidemiol. 1997;145(8):730–7.CrossRefPubMed Doherty MC, Garfein RS, Vlahov D, et al. Discarded needles do not increase soon after the opening of a needle exchange program. Am J Epidemiol. 1997;145(8):730–7.CrossRefPubMed
14.
go back to reference Walker JL. The diffusion of innovations among the American states. Am Polit Sci Rev. 1969;63:880–99.CrossRef Walker JL. The diffusion of innovations among the American states. Am Polit Sci Rev. 1969;63:880–99.CrossRef
15.
go back to reference Berry FS, Berry WD. State lottery adoptions as policy innovations: an event history analysis. Am Polit Sci Rev. 1990;84(2):395–415.CrossRef Berry FS, Berry WD. State lottery adoptions as policy innovations: an event history analysis. Am Polit Sci Rev. 1990;84(2):395–415.CrossRef
20.
go back to reference Meyerson BE, Barnes PR, Emetu RE, Bailey MM, Ohmit A, Gillespie A. Institutional and structural barriers to HIV testing: elements for a theoretical framework. AIDS Patient Care & STDs. 2014;28(1):22–7.CrossRefPubMed Meyerson BE, Barnes PR, Emetu RE, Bailey MM, Ohmit A, Gillespie A. Institutional and structural barriers to HIV testing: elements for a theoretical framework. AIDS Patient Care & STDs. 2014;28(1):22–7.CrossRefPubMed
23.
go back to reference Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths—United States, 2000–2014. MMWR. 2016;64(50):1378–82.PubMed Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths—United States, 2000–2014. MMWR. 2016;64(50):1378–82.PubMed
24.
go back to reference Larrison CR, Hack-Ritzo S, Koerner BD, Schoppelrey SL, Ackerson BJ, Korr WS. State budget cuts, health care reform, and a crisis in rural community mental health agencies. Psychiatr Serv. 2011;62(11):1255–7.CrossRefPubMed Larrison CR, Hack-Ritzo S, Koerner BD, Schoppelrey SL, Ackerson BJ, Korr WS. State budget cuts, health care reform, and a crisis in rural community mental health agencies. Psychiatr Serv. 2011;62(11):1255–7.CrossRefPubMed
25.
go back to reference Substance Abuse and Mental Health Services Administration. Behavioral health barometer: Indiana, 2014. HHS Publication No. SMA-15-4895IN. Rockville: Substance Abuse and Mental Health Services Administration; 2015. Substance Abuse and Mental Health Services Administration. Behavioral health barometer: Indiana, 2014. HHS Publication No. SMA-15-4895IN. Rockville: Substance Abuse and Mental Health Services Administration; 2015.
26.
go back to reference National survey of substance abuse treatment services (n-SSATS), 2013. Department of Health and Human Services Substance Abuse and Mental Health Services Administration. National survey of substance abuse treatment services (n-SSATS), 2013. Department of Health and Human Services Substance Abuse and Mental Health Services Administration.
27.
go back to reference Ostrom E. A diagnostic approach for going beyond panaceas. Proc Natl Acad Sci USA 2007;104:15181–7 (serial online). Available from: JSTOR Journals, Ipswich, MA. Accessed 29 Sep 2016. Ostrom E. A diagnostic approach for going beyond panaceas. Proc Natl Acad Sci USA 2007;104:15181–7 (serial online). Available from: JSTOR Journals, Ipswich, MA. Accessed 29 Sep 2016.
28.
go back to reference Hess C, Ostrom E. Introduction. In: Understanding knowledge as a commons: from theory to practice. Cambridge: The MIT Press; 2011. Hess C, Ostrom E. Introduction. In: Understanding knowledge as a commons: from theory to practice. Cambridge: The MIT Press; 2011.
29.
go back to reference Esteva G. Commoning in the new society. Community Dev J. 2014;49(Suppl 1):i144–59.CrossRef Esteva G. Commoning in the new society. Community Dev J. 2014;49(Suppl 1):i144–59.CrossRef
30.
go back to reference Howard J, Wheeler J. What community development and citizen participation should contribute to the new global framework for sustainable development. Community Dev J. 2015;50(4):552–70.CrossRef Howard J, Wheeler J. What community development and citizen participation should contribute to the new global framework for sustainable development. Community Dev J. 2015;50(4):552–70.CrossRef
31.
go back to reference Hess C. Mapping the new commons. Working Paper W08-21. In: Presented at “Governing Shared Resources: Connecting Local Experience to Global Challenges”; the 12th biennial conference of the International Association for the Study of the Commons, University of Gloucestershire, Cheltenham, England, 14–18 July 2008. Hess C. Mapping the new commons. Working Paper W08-21. In: Presented at “Governing Shared Resources: Connecting Local Experience to Global Challenges”; the 12th biennial conference of the International Association for the Study of the Commons, University of Gloucestershire, Cheltenham, England, 14–18 July 2008.
33.
go back to reference Meyerson BE. Syringe access in Indiana: testimony before the Interim Study Committee on Public Health, Behavioral Health and Human Services, 24 August 2015. Meyerson BE. Syringe access in Indiana: testimony before the Interim Study Committee on Public Health, Behavioral Health and Human Services, 24 August 2015.
Metadata
Title
Against the Odds: Syringe Exchange Policy Implementation in Indiana
Authors
Beth E. Meyerson
Carrie A. Lawrence
Laura Miller
Anthony Gillespie
Daniel Raymond
Kristen Kelley
D. J. Shannon
Publication date
01-04-2017
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1688-7

Other articles of this Issue 4/2017

AIDS and Behavior 4/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.